Proteins are the most advanced nanotechnology we know of. Engineered proteins such as new antibodies, enzymes, gene therapy vectors and motor proteins will be at the core of the biorevolution and change how we think about curing diseases, manufacturing products and designing new materials.
At Adaptyv Bio we're building a next-generation protein foundry. We combine advanced robotics, microfluidics and synthetic biology techniques to create fully automated protein engineering workcells that allow users to synthesize and test any protein they design.
15.02.2024
Student VC Founderful Campus starts a new chapter (startupticker.ch)
01.06.2023
CHF 100'000 for Adaptyv Bio and Hexem (startupticker.ch)
17.04.2023
Adaptyv Bio launches its protein-engineering platform (startupticker.ch)
14.04.2022
S2S Ventures completes first investment deal (startupticker.ch)
15.03.2022
First Wingman Campus Fund supported startups revealed (startupticker.ch)
No milestones
No Jobs
No videos and documents
Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.
Website:
adaptyvbio.com
Headquarter:
Epalinges
Foundation Date:
November 2021
Technology:
Sectors: